Cost-effectiveness of universal influenza vaccination in a pregnant population

Obstetrics and Gynecology

Volumn 107, Issue 6, 2006, Pages 1323-1329

  Roberts, Scott ^a   Hollier, Lisa M ^b   Sheffield, Jeanne ^b   Laibl, Vanessa ^b   Wendel, George D ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; QUALITY OF LIFE; SEASONAL VARIATION; ADOLESCENT; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; IMMUNOLOGY; MONTE CARLO METHOD; ORTHOMYXOVIRUS; PREGNANCY COMPLICATION; PREVENTIVE HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR;

ADOLESCENT; ADULT; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MONTE CARLO METHOD; ORTHOMYXOVIRIDAE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; QUALITY-ADJUSTED LIFE YEARS;

EID: 33745604032     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000210225.45986.99     Document Type: Article

References (49)

1. Noble GR. Epidemiological and clinical aspects of influenza. In: Beare AS, editor. Basic and applied influenza research. Boca Raton (FL): CRC Press; 1982. p. 11-50.
2. Harris JW. Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases. JAMA 1919;72: 978-80.
3. Widelock D, Csizmas L, Klein S. Influenza, pregnancy, and fetal outcome. Public Health Rep 1963;78:1-11.
4. Freeman DW, Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol 1959;78:1172-5.
5. Shahab SZ, Glezen WP. Influenza virus. In: Gonik B, editor. Viral diseases in pregnancy. New York (NY): Springer-Verlag; 1994. p. 215-23.
6. Schoenbaum SC, Weinstein L. Respiratory infection in pregnancy. Clin Obstet Gynecol 1979;22:293-300.
7. Kirshon B, Faro S, Zurawin RK, Samo TC, Carpenter RJ. Favorable outcome after treatment with amantadine and ribavirin in a pregnancy complicated by influenza pneumonia: a case report. J Reprod Med 1988;33:399-401.
8. Kort BA, Cefalo RC, Baker VV. Fatal influenza A pneumonia in pregnancy. Am J Perinatol 1986;3:179-82.
9. Irving WL, James DK, Stephenson T, Laing P, Jameson C, Oxford JS, et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG 2000;107:1282-9.
10. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP) [Published erratum appears in MMWR Morb Mortal Wkly Rep. 2005;54: 750]. MMWR Recomm Rep 2005;54(RR-8):1-40.
11. Immunization during pregnancy. ACOG Committee Opinion No. 282. American College Of Obstetricians and Gynecologists. Obstet Gynecol 2003;101:207-12.
12. Munoz FM, Greisinger AJ, Wehmanen OA, Mouzoon ME, Hoyle JC, Smith FA, et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2005;192:1098-106.
13. Heinonen OP, Shapiro S, Monson RR, Hartz SC, Rosenberg L, Slone D. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiol 1973;2:229-35.
14. Acs N, Banhidy F, Puho E, Czeizel AE. Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Res A Clin Mol Teratol 2005;73: 989-96.
15. Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 2000;284:1655-63.
16. Nichol KL, Lind A, Margolis KL, Murdoch M, McFadden R, Hauge M, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995;333: 889-93.
17. Simonsen L, Fukuda K, Schonberger LB, Cox NJ. Impact of influenza epidemics on hospitalizations. J Infect Dis 2000;181: 831-7.
18. Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol 1980;112: 798-811.
19. Hartert TV, Neuzil KM, Shintani AK, Mitchel EF Jr, Snowden MS, Wood LB, et al. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol 2003;189: 1705-12.
20. Tuyishime JD, De Wals P, Moutquin JM, Frost E. Influenza-like illness during pregnancy: results from a study in the eastern townships, Province of Quebec. J Obstet Gynaecol Can 2003;25:1020-5.
21. Gold MR, Siegel JE, Russel LB, Weinstein MC, editors. Cost-effectiveness in health and medicine. New York (NY): Oxford University Press; 1996.
22. Kendal AP, Pereria MS, Skehel JL. Concepts and procedures for laboratory-based influenza surveillance. Geneva (Switzerland): World Health Organization; 1982.
23. Nichol KL. Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults. Vaccine 1999;17:S67-73.
24. Hayden FG, Osterhaus A, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. GG167 Influenza Study Group. N Engl J Med 1997;337: 874-80.
25. Monto AS, Robinson DP, Herlocher ML, Hinson JM Jr, Elliott MJ, Crisp A. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. JAMA 1999;282:31-5.
26. Wilde JA, McMillan JA, Serwint J, Butta J, O'Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA 1999;281:908-13.
27. Harlan WR, Murt HA, Thomas W, Lepkowski JM, et al. Incidence, utilization, and costs associated with acute respiratory conditions. In: National medical care utilization and expenditure survey. Hyattsville (MD): U.S. Public Health Service, National Center for Health Statistics, Division of Health Interview Statistics; 1986:4-7.
28. Muennig P. Designing and conducting cost-effectiveness analyses in medicine and health care. San Francisco (CA): Jossey-Bass; 2002. p. 167-89.
29. Centers for Medicare and Medicaid Services. CMS Manual System. Pub. 100-04 Medicare Claims Processing. Available at: http://new.cms.hhs.gov/ InpatientRehabFacPPS/downloads/R263CP.pdf. Retrieved October 18, 2005.
30. Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000;283:1016-24.
31. U.S. Census Bureau. Available at: http://www.census.gov/statab/. Retrieved October 18, 2005.
32. Keech M, Scott AJ, Ryan PJ. The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. Occup Med (Lond) 1998; 48:85-90.
33. Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, et al. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 1998;339: 1797-802.
34. Kaplan RM, Anderson JP. A general health policy model: update and applications. Health Serv Res 1988;23:203-35.
35. Schrag SJ, Fiore AE, Gonik B, Malik T, Reef S, Singleton JA, et al. Vaccination and perinatal infection prevention practices among obstetrician-gynecologists. Obstet Gynecol 2003;101: 704-10.
36. Mauskopf JA, Cates SC, Griffin AD. A pharmacoeconomics model for the treatment of influenza. Pharmacoeconomics 1999;16:73-84.
37. Nichol KL. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch Intern Med 2001;161:749-59.
38. Monto AS, Ohmit SE, Margulies JR, Talsma A. Medical practice-based influenza surveillance: viral prevalence and assessment of morbidity. Am J Epidemiol 1995;141:502-6.
39. Adams PF, Hendershot GE, Marano MA; Centers for Disease Control and Prevention/National Center for Health Statistics. Current estimates from the national health interview survey, 1996. Vital Health Stat 10 1999;10:1-212.
40. Campbell DS, Rumley MH. Cost-effectiveness of the influenza vaccine in a healthy, working-age population. J Occup Environ Med 1997;39:408-14.
41. Healthcare Cost and Utilization Project. National and Regional Statistics from the NIS. Available at: http://hcup.ahrq.gov/ HcupNet.asp?ID= 2143D0ED8342917B&Form=SelDB&GoTo=MAINSEL&JS=. Retrieved October 18, 2005.
42. U.S. Department of Labor. Bureau of Labor Statistics. National Compensation Survey. NCS: Occupational Wages in the United States, Bulletin, 2002. Available at: http://www.bls. gov/ncs/ocs/sp/ncb10552.pdf. Retrieved October 15, 2005.
43. Gold MR, Franks P, McCoy KI, Fryback DG. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care 1998;36:778-92.
44. Muennig PA, Khan K. Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults. Clin Infect Dis 2001;33:1879-85.
45. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46(RR-9): 1-5.
46. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1993;42(RR-6):5.
47. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000;342: 225-31.
48. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998;148:1094-102.
49. Puck JM, Glezen WP, Frank AL, Six HR. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis 1980;142:844-9.